PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $57,226,239 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $57,705,797 | 0.31% |
| Boxer Capital, LLC | 699,047 | $3,985 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 47,614 | $271 | 0.03% |
| DENALI ADVISORS LLC | 8,200 | $46,740 | 0.02% |
| 683 Capital Management, LLC | 28,631 | $163,197 | 0.01% |
| Virtu Financial LLC | 11,201 | $64 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 2,273,894 | $12,961,196 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $210,609 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 84,667 | $482,602 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 90,200 | $514,140 | 0.00% |
| Tower Research Capital LLC (TRC) | 13,352 | $76 | 0.00% |
| FMR LLC | 9,093,356 | $51,832,128 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 16,198 | $92,329 | 0.00% |
| HRT FINANCIAL LP | 22,175 | $126 | 0.00% |
| China Universal Asset Management Co., Ltd. | 649 | $4 | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 514,548 | $2,932,924 | 0.00% |
| Cutler Group LLC / CA | 2,130 | $12 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,922 | $62,255 | 0.00% |
| TWO SIGMA ADVISERS, LP | 50,500 | $287,850 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q1 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.